Delayed Thyroid Metastasis from Clear Cell Renal Cell Carcinoma: A Case Study Highlighting Diagnostic Challenges Due to Cytologic and Radiologic Discrepancies
-
By
-
Seok-Kyung Kang
-
Miri Ryu
-
Seungju Lee
-
June 12, 2026
Clinical Report: Delayed Thyroid Metastasis from Clear Cell Renal Cell Carcinoma
Overview
This case study presents a 55-year-old man with delayed thyroid metastasis from clear cell renal cell carcinoma (RCC) diagnosed 10 years post-nephrectomy. It emphasizes the diagnostic challenges posed by cytologic and radiologic discrepancies in identifying metastatic disease.
Background
Clear cell renal cell carcinoma (RCC) is known for its high metastatic potential, often presenting many years after initial treatment. Although thyroid metastasis is rare, RCC is one of the most common primary malignancies to metastasize to the thyroid. Accurate diagnosis is critical for effective management, as distinguishing between metastatic and primary thyroid tumors can be challenging.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
- Thyroid metastasis from RCC can occur many years after nephrectomy, complicating diagnosis.
- Fine-needle aspiration cytology (FNAC) may yield indeterminate results, necessitating further investigation.
- Histopathological examination and immunohistochemistry are essential for confirming metastatic RCC in the thyroid.
- Core needle biopsy should be considered when cytologic-radiologic discordance is present.
- Management of isolated metastatic disease requires a multidisciplinary approach, including surgical resection and systemic therapy.
Clinical Implications
Healthcare professionals should maintain a high index of suspicion for metastatic disease in patients with a history of RCC presenting with new thyroid nodules or cervical lymphadenopathy. Early intervention and a comprehensive diagnostic approach are crucial for optimal patient outcomes.
Conclusion
This case underscores the importance of recognizing the potential for late thyroid metastasis in RCC and the need for thorough diagnostic evaluation to guide management strategies.
Related Resources & Content
- Frontiers in Surgery, 2026 -- Diagnosis and treatment of breast cancer metastasis to thyroid: a case report and literature review
- Frontiers in Oncology, 2026 -- Renal clear cell carcinoma with co-existing tumor thrombosis of renal vein and ureter: a case report and review of the literature
- Frontiers in Oncology, 2026 -- Synchronous lung adenocarcinoma in situ and type B2-B3 thymoma in a frozen hemithorax: a case report and multidisciplinary approach
- Metastatic Involvement of the Bowel in Undifferentiated Thyroid Carcinoma: A Case Study and Review of Existing Literature
- Clear Cell Renal Cell Carcinoma Metastasis to the Thyroid: A Narrative Review of the Literature | MDPI
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - ScienceDirect
- 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management - PMC
- Clear Cell Renal Cell Carcinoma Metastasis to the Thyroid: A Narrative Review of the Literature | MDPI
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - ScienceDirect
- 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management - PMC
Based on findings from:
Case Report: Decade-delayed thyroid metastasis with cervical lymph node involvement from clear cell renal cell carcinoma: diagnostic pitfalls of cytologic-radiologic discordance
Seok-Kyung Kang, Miri Ryu, Seungju Lee. Frontiers In Oncology, 2026.
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1878908/full
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.